RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 164 filers reported holding RELAY THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $323 | +23.8% | 38,414 | +120.1% | 0.00% | +33.3% |
| Q4 2022 | $261 | -99.9% | 17,450 | +43.6% | 0.00% | 0.0% |
| Q3 2022 | $272,000 | -80.6% | 12,151 | -85.5% | 0.00% | -80.0% |
| Q2 2022 | $1,405,000 | +3.8% | 83,864 | +85.4% | 0.02% | +50.0% |
| Q1 2022 | $1,354,000 | -7.7% | 45,223 | -5.3% | 0.01% | +25.0% |
| Q4 2021 | $1,467,000 | -48.7% | 47,775 | -47.3% | 0.01% | -38.5% |
| Q3 2021 | $2,861,000 | +175.4% | 90,740 | +219.6% | 0.01% | +160.0% |
| Q2 2021 | $1,039,000 | -4.6% | 28,389 | -9.9% | 0.01% | -16.7% |
| Q1 2021 | $1,089,000 | +11.5% | 31,510 | +34.1% | 0.01% | +20.0% |
| Q4 2020 | $977,000 | – | 23,504 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 10,551,115 | $438,504,000 | 37.66% |
| TRV GP IV, LLC | 2,811,197 | $116,833,000 | 37.48% |
| Foresite Capital Management V, LLC | 400,000 | $16,624,000 | 12.31% |
| Foresite Capital Management IV, LLC | 2,139,380 | $88,913,000 | 9.66% |
| EcoR1 Capital, LLC | 3,200,649 | $133,019,000 | 7.15% |
| BVF INC/IL | 3,073,147 | $127,720,000 | 5.02% |
| Casdin Capital, LLC | 3,808,894 | $158,298,000 | 4.69% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $1,159,730,000 | 4.67% |
| Grace Capital | 164,389 | $6,832,000 | 4.32% |
| Alphabet Inc. | 1,801,490 | $74,870,000 | 3.59% |